Skip to content

Clinical evidence-based evaluation and mechanism discussion of Jiawei Taohong Siwu decoction combined with pressure in the treatment of venous leg ulcer (qi deficiency and blood stasis pattern).

Clinical evidence-based evaluation and mechanism discussion of Jiawei Taohong Siwu decoction combined with pressure in the treatment of venous leg ulcer (qi deficiency and blood stasis pattern).

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000053
Enrollment
Unknown
Registered
2026-01-13
Start date
2024-10-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous leg ulcer (qi deficiency and blood stasis syndrome)

Interventions

Experimental group:Modified Taohong Siwu Decoction granules combined with compression therapy
control group:Placebo granules combined with routine dressing changes

Sponsors

Wangjing Hospital No. 6 Zhonghuan South Road Wangjing Chaoyang District Beijing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of VLU and eczema (qi deficiency and blood stasis syndrome) and the ulcer has not healed for more than 2 weeks. (2) Be between the ages of 18-80. (3) There is no restriction on gender. (4) 1cm2= wound area = 50cm2. (5) The CEAP classification belongs to C5 and C6. (6) Voluntarily participate in this trial and sign the informed consent form; The signing of the informed consent form is in accordance with GCP requirements.

Exclusion criteria

Exclusion criteria: (1) Patients with moderate to severe ischemia in lower limb arteries and lower limb ankle-brachial index (ABI) < 0.8. (2) Those who suffer from local necrosis or severe infection and need amputation. (3) Patients with severe basic internal diseases such as heart brain liver kidney and respiratory system and need to have stable vital signs. (4) Pregnant and lactating women. (5) Suspected or confirmed to have a history of alcohol drug abuse and psychosis. (6) Those with allergies or allergies to the drugs in this study. (7) Those who have participated in other clinical trials in the past 1 month.

Design outcomes

Secondary

MeasureTime frame
Wound healing time;TCM Syndrome Points;The speed at which the wound heals;

Primary

MeasureTime frame
Wound healing rate;

Countries

China

Contacts

Public ContactWu Xin

Wangjing Hospital No. 6 Zhonghuan South Road Wangjing Chaoyang District Beijing

13146172181@163.com13146172181

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 7, 2026